US1947519A - Medicinal oil solutions - Google Patents
Medicinal oil solutions Download PDFInfo
- Publication number
- US1947519A US1947519A US551560A US55156031A US1947519A US 1947519 A US1947519 A US 1947519A US 551560 A US551560 A US 551560A US 55156031 A US55156031 A US 55156031A US 1947519 A US1947519 A US 1947519A
- Authority
- US
- United States
- Prior art keywords
- alkylamine
- organo
- oil
- ephedrine
- mineral oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 23
- 150000001875 compounds Chemical class 0.000 description 13
- 239000002480 mineral oil Substances 0.000 description 13
- 235000010446 mineral oil Nutrition 0.000 description 12
- 150000003973 alkyl amines Chemical class 0.000 description 11
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 11
- 229960002179 ephedrine Drugs 0.000 description 11
- 150000002902 organometallic compounds Chemical class 0.000 description 11
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000000344 soap Substances 0.000 description 8
- -1 alkylamine salt Chemical class 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000010775 animal oil Substances 0.000 description 3
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- XKNKHVGWJDPIRJ-UHFFFAOYSA-N arsanilic acid Chemical compound NC1=CC=C([As](O)(O)=O)C=C1 XKNKHVGWJDPIRJ-UHFFFAOYSA-N 0.000 description 1
- 229950002705 arsanilic acid Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 125000000950 dibromo group Chemical group Br* 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940059904 light mineral oil Drugs 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940103494 thiosalicylic acid Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Definitions
- An object 01' our invention is to produce solutions, or stable colloidal suspensions, of acidic organo-metallic compounds in mineral oil.
- These compounds have the general formula HOR where R, is an organo-metallic, preferably a mercurated aromatic, residue, and they are not normally soluble in mineral oil.
- Such object is efiected by first forming an alkylamine salt of the organo-metal: compound (if the compound is not already in the form of an alkylamine salt) and then adding an alkylamine soap, thereby peptizing the salt so that it will form a solution or stable colloidal suspension in mineral oil.
- the invention can be practiced in various ways, although, in certain cases, we find it desirable first to prepare a soap by combining suitable amounts of an amine and a fatty acid (not necessarily by molecular weights of the materials, as the presence of an excess of either one of them usually is notv objectionable), and then incorporating the alkyl'amine soap and the salt of the organo-metalliccompound with the oil. In other cases it is possible to practice the process with a difierent step sequence.
- Example 4 grams of finely divided 4-nitro anhydrohydroxy mercuri-orthocresol is mixed with 92 grams of ephedrine at a temperature not exceeding 60 C. and allowed to stand until the reaction is complete.
- Ephedrine laurate is prepared by mixing 8.26 grams (1 molecular equivalent) of ephedrine with 10 grams of lauric acid at 60 C. The two preparations are then mixed together at about 60 0., following which there is added surficient neutral oil (preferably light mineral oil) to make a total weight of 10,000 grams. The mixture is stirred until solution results.
- surficient neutral oil preferably light mineral oil
- Amine Oil insoluble compound Fatty acid Ephedrine...- 4-nitro-1acetoxy mercuri ortho- Erucic.
- a process of preparing a stable mineral oil solution of an acidic organo-metallic compound which normally is insoluble in mineral oil comprising forming an alkylamine salt of said com- .alkylamine is ephedrine.
- a pharamaceutical comprising a stable solution in a mineral oil, which is liquid at ordinary temperatures, of an alkylamine salt of an organometallic compound, and, as a stabilizing agent, an alkylamine soap.
- composition as defined in claim 4 wherein said alkylamine is ephedrinei 6.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Patented Feb. 20, 1934 UNITED STATES PATENT orrics MEDICINAL OIL SOLUTIONS Illinois No Drawing. Application July 17, 1931 Serial No. 551,560
9 Claims.
An object 01' our invention is to produce solutions, or stable colloidal suspensions, of acidic organo-metallic compounds in mineral oil. These compounds have the general formula HOR where R, is an organo-metallic, preferably a mercurated aromatic, residue, and they are not normally soluble in mineral oil.
Such object is efiected by first forming an alkylamine salt of the organo-metal": compound (if the compound is not already in the form of an alkylamine salt) and then adding an alkylamine soap, thereby peptizing the salt so that it will form a solution or stable colloidal suspension in mineral oil.
We have not proven' that the solutes are in molecular dispersion, but since the products have the appearance and, insofar as we have determined, the properties of true solutions, we will refer to them as solutions.
It is well known that certain mercurated phenolic compounds and other organo-metallic compounds are effective therapeutic agents. Many of these compounds are relatively insoluble in water, and are used in the form of their water-soluble salts. The compounds and their salts in general are also insoluble in mineral oils. For application to certain tissues and areas, as for mucous membranes, it is frequently desirable to employ the product in oil solution, preferably mineral oil. While solutiops or colloidal suspensions of mineral oil insoluble materials have heretofore been prepared in animal. and vegetable oils, such solutions or suspensions are not desirable, especially for pharmaceutical purposes, because of the lack of chemical stability of such media, e. g., their susceptibility to oxidation, whereby they become thick and gummy, and also their susceptibility to rancidiflcation. Attempts have been made to overcome this disadvantage by first dissolving the materials in animal or vegetable oils, and then dissolving such solutions in a mineral oil. However, these preparations, also, are undesirable because of their large content of animal or vegetable oil, which have the disadvantages just indicated. These disadvantages are lacking where the fluid carrier is composed principally of mineral oil.
. It will be understood, of course, that the presence of a small amount of animal or vegetable oil, in
quantities insuflicient to stabilize the solution, is not highly objectionable.
We have discovered that these compounds, when in the form of their alkylamine salts, can be peptized by alkylamine soaps so that when they are added to a mineral oil, a solution results.
In order that a therapeutic agent may exert its full bactericidal value, it is sometimes advantageous to have the agent dissolved in oil in the form of a water-soluble salt. This may therefore be accomplished by our invention. We have also found that it is possible to select certain alkylamines for use in these compounds which themselves exert therapeutic actions and which thereby enhance the therapeutic desirability of the therapeutic constituents of the compounds obtained.
General method.-The invention can be practiced in various ways, although, in certain cases, we find it desirable first to prepare a soap by combining suitable amounts of an amine and a fatty acid (not necessarily by molecular weights of the materials, as the presence of an excess of either one of them usually is notv objectionable), and then incorporating the alkyl'amine soap and the salt of the organo-metalliccompound with the oil. In other cases it is possible to practice the process with a difierent step sequence.
Example 4 grams of finely divided 4-nitro anhydrohydroxy mercuri-orthocresol is mixed with 92 grams of ephedrine at a temperature not exceeding 60 C. and allowed to stand until the reaction is complete. Ephedrine laurate is prepared by mixing 8.26 grams (1 molecular equivalent) of ephedrine with 10 grams of lauric acid at 60 C. The two preparations are then mixed together at about 60 0., following which there is added surficient neutral oil (preferably light mineral oil) to make a total weight of 10,000 grams. The mixture is stirred until solution results. The proportions given result in a composition containing the ephedrine salt of the acidic organo-metallic compound, an ephedrine soap as stabilizing agent, with a certain quantity of ephedrine remaining uncombined, the latter having been added in excess of its combining proportion. This free ephedrine is of value in the product, inasmuch as it lessens the congestion and shrinks the swollen mucosa, and thus provides a better opportunity for the organo-metallic salt to contact with the invading organisms and exert its antiseptic action.
The following preparations may be made similarly, the alkylamine salt of the organo-metallic compound and the alkylamine soap of the fatt acid being formed in each case:
Amine Oil insoluble compound Fatty acid Ephedrine...- 4-nitro-1acetoxy mercuri ortho- Erucic.
creso Do do Palmitic. Do do Stearic. Do do Laurie. Do 4-nitro-anhydro hydroxy mercuri Erucic.
orthocteso Do .d0 Palmitic. Dn dn Laurie. Dn fin Oleic. Dn do Coconut oil acids. Do Ethyl mercurl thiosalicylic acid Oleic. Do Hydroxy mercuri sallcyl oxyace- Do.
tic acid. Do 0xy-mercuri ortho-m'trophenoL Do. Do 2.7 dibromo 4-bydroxy mercuri Do.
fluorescein. Do Arsanilic acid Do. Do 4-(hydr9xy ethyl amlno)-phenyl D0.
arsomc aci A P s e u d o E p h- 4-nitro-anbydro hydroxy mercuri Do.
ednne. v orthocresol. Triethanolamine- 'Do. Tributylamine- Do. Dibutyl amin 0 Do.
ropanol. Dibutylamine.-- Do. Diethylamine Do.
In thepreparation of such solutions, it is occasionally advantageous to add alcohol or water to the mixture of the amine and the acidic organo-metallic compound to aid the reaction between the two compounds. The solvent is then removed before proceeding with the next step.
Various modifications and changes in proportions and substitutions of equivalents coming within the scope of our invention will doubtless occur to those skilled in the art. Hence, we do not wish to be limited to the precise embodiments disclosed above except as set forth in the appended claims which are to be interpreted as broadly as the state of the art will permit.
We claim as our invention:
1. The improvement in the art of preparing a stable oil solution of an acidic organo-mercuri compound which normally is insoluble in oil, which compound is adaptable for application to the mucus membrane of the human body, said process consisting in forming an alkyl amine salt of said compound and incorporating said salt and an alkyl amine soap in a mineral oil which is liquid at ordinary temperatures.
2. A process of preparing a stable mineral oil solution of an acidic organo-metallic compound which normally is insoluble in mineral oil, comprising forming an alkylamine salt of said com- .alkylamine is ephedrine.
4. A pharamaceutical comprising a stable solution in a mineral oil, which is liquid at ordinary temperatures, of an alkylamine salt of an organometallic compound, and, as a stabilizing agent, an alkylamine soap.
5. A composition as defined in claim 4, wherein said alkylamine is ephedrinei 6. A composition as defined in claim 4, wherein said organo-metallic compound is a phenolic mercurial.
7. A composition as defined in claim 4, wherein said organo-metallic compound is a phenolic mercurial, and said alkylamine is ephedrine.
8. A composition as defined in claim 4, wherein said organo-metallic compound is 4-nitro-anhydro-hydroxy-mercurio-ortho-cresol and said alkylamine is ephedrine.
9.- A combination as defined in claim 4, wherein the alkylamine is ephedrine and is present in excess.
EDGAR B. CARTER. EDMOND E. MOORE.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US551560A US1947519A (en) | 1931-07-17 | 1931-07-17 | Medicinal oil solutions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US551560A US1947519A (en) | 1931-07-17 | 1931-07-17 | Medicinal oil solutions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US1947519A true US1947519A (en) | 1934-02-20 |
Family
ID=24201766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US551560A Expired - Lifetime US1947519A (en) | 1931-07-17 | 1931-07-17 | Medicinal oil solutions |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US1947519A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2423121A (en) * | 1942-05-16 | 1947-07-01 | Frank J Sowa | Reaction product of phenyl mercury salts with hydroxy alkyl amino compounds and their preparation |
| US2423261A (en) * | 1943-06-04 | 1947-07-01 | Frank J Sowa | Germicidal product and method of producing same |
-
1931
- 1931-07-17 US US551560A patent/US1947519A/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2423121A (en) * | 1942-05-16 | 1947-07-01 | Frank J Sowa | Reaction product of phenyl mercury salts with hydroxy alkyl amino compounds and their preparation |
| US2423261A (en) * | 1943-06-04 | 1947-07-01 | Frank J Sowa | Germicidal product and method of producing same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2701781A (en) | Aqueous chlorine dioxide antiseptic compositions and production thereof | |
| DE60126433T2 (en) | PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS | |
| GB474240A (en) | Manufacture of a new phenol derivative and its use for the preparation of mineral oil compositions | |
| JPH06507913A (en) | Novel compositions based on derivatives of taxanes | |
| US2550622A (en) | Ointment base and iodine ointment | |
| JPH0454646B2 (en) | ||
| US1947519A (en) | Medicinal oil solutions | |
| JP2556332B2 (en) | Transparent gel composition | |
| US1921722A (en) | Solvent for remedies | |
| US2252863A (en) | Quaternary ammonium salts | |
| USRE19231E (en) | Medicinal oh | |
| US2277854A (en) | Colloidal tertiary calcium phosphate | |
| US2028575A (en) | Colloidal copper solution | |
| US2250390A (en) | Colloidal silver iodide composition | |
| US2272484A (en) | Therapeutic compositions | |
| US2833690A (en) | Magnesium hydroxide suspensions containing sea-plant hydrocolloid | |
| US2414213A (en) | Oil-soluble copper-nicotine compounds and process of preparing same | |
| US2025869A (en) | Solutions of alkoxyphenols | |
| US2850426A (en) | Anthelmintic piperazine-phosphoric acid compositions and method of combatting helminth infestations therewith | |
| US3159539A (en) | Water-soluble antiseptic agent | |
| US2249023A (en) | Method of preparing colloidal silver iodide composition and the product | |
| US1536301A (en) | Prophylatic detergent | |
| US2037196A (en) | Mixture of and method of admixing sodium morrhuate and quinine solution | |
| US2266993A (en) | Calcium salt and method of preparation | |
| US2099432A (en) | Reaction products of glycols and alkaloids |